Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.18) by 5.56 percent. The company reported quarterly sales of $4.50 million which beat
Bitcoin traded below a key psychological level on Monday evening, while other major coins also slid, as the global cryptocurrency market declined 4.05% to $888.7 billion at press time.